Table 2.
Treatments1 | SEM | P < | |||||
---|---|---|---|---|---|---|---|
Item | Control | ANT | ADY | EDY | MDY | ||
BW, kg | |||||||
Initial | 448 | 448 | 448 | 448 | 448 | 8.4 | 1.00 |
Final | 627 | 623 | 628 | 625 | 631 | 10.9 | 0.99 |
DMI, kg/d | |||||||
Day 1–28 | 9.97a | 8.82b | 10.11a | 9.81a | 10.35a | 0.32 | 0.01 |
Day 29–56 | 11.32 | 10.76 | 11.73 | 11.62 | 11.60 | 0.35 | 0.32 |
Day 57–84 | 11.35 | 11.18 | 11.95 | 12.17 | 12.05 | 0.40 | 0.31 |
Day 85–112 | 11.42 | 11.39 | 11.70 | 11.75 | 11.85 | 0.38 | 0.88 |
Overall | 11.0a,b | 10.5b | 11.4a | 11.3a | 11.5a | 0.20 | 0.05 |
ADG, kg/d | |||||||
Day 1 to 28 | 1.84b | 1.57c | 1.78b | 1.85b | 2.13a | 0.12 | 0.04 |
Day 29 to 56 | 1.74a,b | 1.92a | 1.80a | 1.51b | 1.49b | 0.11 | 0.02 |
Day 57 to 84 | 1.40 | 1.31 | 1.50 | 1.65 | 1.64 | 0.11 | 0.13 |
Day 85 to 112 | 1.40 | 1.46 | 1.36 | 1.27 | 1.27 | 0.09 | 0.50 |
Overall | 1.59 | 1.57 | 1.61 | 1.57 | 1.63 | 0.06 | 0.94 |
G:F, g/kg | |||||||
Day 1 to 28 | 186.0 | 176.9 | 174.9 | 188.5 | 205.6 | 10.8 | 0.29 |
Day 29 to 56 | 155.4b | 178.6a | 154.2b | 130.6c | 128.4c | 8.4 | 0.01 |
Day 57 to 84 | 122.2 | 114.1 | 125.6 | 135.7 | 136.4 | 8.1 | 0.26 |
Day 85 to 112 | 123.1 | 130.6 | 115.1 | 110.0 | 106.5 | 7.7 | 0.18 |
Overall | 146.7 | 150.1 | 142.5 | 141.2 | 144.2 | 4.7 | 0.58 |
a,b,cLeast square means within a row with different superscripts differ (P < 0.05).
1Control = no yeast and no antibiotics; ANT (330 mg monensin + 110 mg tylosin·steer−1d−1); ADY (1.5 g ADY·steer−1d−1); EDY (3 g·steer−1d−1; EDY consisted of 1.5 g ADY and 1.5 g capsule material); and MDY (1.5 g ADY + 3.0 g EDY·steer−1d−1); Treatment × days on-feed were significant at P < 0.05 for DMI, ADG, and G:F.